Mr. Moon Su Eun
President
Mirfeel Korea Co., Ltd.
77 Hwanggeum-ro 323 beon-gil
Yangchon-eup
Gimpo-si
Gyeonggi-do
10049FEI 3016921925Issued Jun 22, 2022Center for Drug Evaluation and Research | CDER
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3016921925.
Violations6
Issue DateJun 22, 2022
Product TypeDrugs
StatusOpen
Letter Details
Firm
Mirfeel Korea Co., Ltd.
Location
Mr. Moon Su Eun
President
Mirfeel Korea Co., Ltd.
77 Hwanggeum-ro 323 beon-gil
Yangchon-eup
Gimpo-si
Gyeonggi-do
10049
FEI Number
3016921925
Country
South Korea
Issue Date
June 22, 2022
Issuing Office
Center for Drug Evaluation and Research | CDER
Product Type
Drugs
Status
Open
Summary
Mirfeel Korea Co., Ltd., a South Korean manufacturer of over-the-counter hand sanitizer products distributed in the U.S., was cited for manufacturing adulterated drugs due to benzene contamination at unacceptable levels, indicating inadequate quality assurance and failure to comply with Current Good Manufacturing Practice (CGMP) requirements. FDA laboratory testing of the company's Moisturizing Hand Sanitizer (Peppermint Scented) revealed the contamination, and subsequent review of the company's submitted records confirmed that their manufacturing methods, facilities, and controls did not conform to CGMP standards under 21 CFR parts 210 and 211. Additionally, the product packaging in 1.01 ounce containers was found to resemble food pouches in a manner that constituted misbranding under FDA regulations.
Mirfeel Korea Co., Ltd. FDA Warning Letter, June 22, 2022